NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Respiratory Medicine > New hope for shock patients in intensive care

New hope for shock patients in intensive care

10 August 2016 · Listed under Respiratory Medicine

DSC_8176crop

Care for critically-ill patients with shock could be improved, it is hoped, after the first successful testing by University of Oxford scientists of a new machine to record oxygen consumption in real time.

The new technology has arisen through a collaboration between Professor Peter Robbins in the Department of Physiology, Anatomy and Genetics and Professors Grant Ritchie and Gus Hancock in the Department of Chemistry.

It combines laser spectroscopy and precise flow measurement of breath in a single medical device which fits into a standard ventilation tube.

The work has received public funding from the NIHR Oxford Biomedical Research Centre and the Medical Research Council.

Professor Peter Robbins, who is directing the research, said: “This is the culmination of many years of development and it has finally come to fruition.

“It is exciting for us to be able to offer something to doctors that has the potential to improve significantly the care of very sick patients.”

Patients in shock suffer a lack of oxygen throughout the body, causing many of their organs to deteriorate and eventually even stop working altogether.

The possible underlying causes of shock include heart attack, haemorrhage, and sepsis. Common treatments include drugs, oxygen, and blood transfusions.

Doctors do not at present have any direct way of measuring how much oxygen is being used by the body, making it difficult for them to judge which treatments are likely to be most beneficial.

Tests in healthy volunteers and in patients having anaesthetics at Oxford’s John Radcliffe Hospital indicate the precision of the device is better than anything previously achieved. The results are published today in Science Advances.

Stuart McKechnie, Consultant in Intensive Care at the John Radcliffe Hospital, said “Though we already monitor critically-ill patients very closely, this device promises to provide highly useful additional information that may help us to care better for patients with sepsis and shock in the future.”

The device is now being used as part of a further study in the Intensive Care units within Oxford University Hospitals NHS Foundation Trust, which runs the John Radcliffe Hospital.

← New hope to tackle third biggest killer disease
A breathless and magical experience for foreign students →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at [email protected]

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre